Tudor Investment Corp’s Genomic Health, Inc. GHDX Stock Holding History

Tudor Investment Corp’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,664	Closed	-$248K	–	1490
2019 Q3	$248K	Sell	3,664 -80,685	-96%	-$5.54M	0.01%	910
2019 Q2	$4.91M	Buy	84,349 +7,073	+9%	+$419K	0.14%	102
2019 Q1	$5.41M	Buy	77,276 +26,991	+54%	+$2M	0.22%	85
2018 Q4	$3.24M	Buy	50,285 +10,762	+27%	+$754K	0.06%	105
2018 Q3	$2.77M	Buy	39,523 +16,483	+72%	+$964K	0.07%	197
2018 Q2	$1.16M	Buy	23,040 +13,068	+131%	+$519K	0.04%	395
2018 Q1	$312K	Buy	+9,972	New	+$331K	0.01%	717
2016 Q4	–	Sell	-7,600	Closed	-$220K	–	1713
2016 Q3	$220K	Sell	7,600 -4,200	-36%	-$117K	0.01%	1209
2016 Q2	$306K	Buy	+11,800	New	+$313K	0.01%	1155
2014 Q1	–	Sell	-15,100	Closed	-$442K	–	1500
2013 Q4	$442K	Buy	+15,100	New	+$479K	0.02%	642

Tudor Investment Corp's GHDX Position: Q4 2019 in Review

Tudor Investment Corp sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 3,664 shares — an estimated $248K sold.

Tudor Investment Corp first reported a position in GHDX in Q4 2013 and held it in 10 quarters. The position peaked at $5.41M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Tudor Investment Corp reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Tudor Investment Corp sold 3,664 Genomic Health, Inc. shares in Q4 2019, an estimated $248K.
Tudor Investment Corp first reported a position in Genomic Health, Inc. in Q4 2013 and held it in 10 quarters.
Tudor Investment Corp's Genomic Health, Inc. position peaked at $5.41M in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Tudor Investment Corp's 13F filing for Q4 2019, filed 14 Feb 2020.